T1	Condition 503 525	cardiovascular disease
T2	Condition-Name 503 525	cardiovascular disease
E1	Condition:T1 Name:T2
T3	Observation 130 147	strength training
T4	Observation-Name 130 147	strength training
E3	Observation:T3 Name:T4 Duration:E10
T6	Condition 668 675	disease
T7	Condition-Name 668 675	disease
E6	Condition:T6 Name:T7
T8	Eq-Temporal-Unit 163 168	years
A1	Eq-Temporal-Unit-Value T8 year
T9	Eq-Temporal-Unit 308 313	weeks
A2	Eq-Temporal-Unit-Value T9 week
T10	Eq-Temporal-Unit 329 334	years
A3	Eq-Temporal-Unit-Value T10 year
T11	Eq-Operator 302 304	to
A4	Eq-Operator-Value T11 BETWEEN
T12	Eq-Operator 341 342	-
A5	Eq-Operator-Value T12 BETWEEN
T13	Eq-Value 161 162	2
T14	Eq-Value 300 301	8
T15	Eq-Value 305 307	12
T16	Eq-Value 327 328	2
T17	Eq-Value 340 341	2
T18	Eq-Value 342 343	4
T19	Eq-Comparison 300 313	8 to 12 weeks
E7	Eq-Comparison:T19 Operator:T11 Value:T14 Value2:T15 Temporal-Unit:T9
T20	Eq-Comparison 340 359	2-4 cycles per year
E8	Eq-Comparison:T20 Operator:T12 Value:T17 Value2:T18 Unit:T35 Per:T36
T21	Drug 25 53	Anabolic androgenic steroids
E2	Drug:T21 Name:T22
T22	Drug-Name 25 53	Anabolic androgenic steroids
T23	Drug 64 92	Anabolic androgenic steroids
E4	Drug:T23 Name:T24
T24	Drug-Name 64 92	Anabolic androgenic steroids
T25	Or 60 63	and
E5	Or:T25 Arg:E2 Arg2:E4
T26	Negation 93 101	nonusers
E9	Negation:T26 Negates:E4
A6	Observation-Type-Value T4 social-habit
T27	Eq-Comparison 152 168	at least 2 years
E10	Eq-Comparison:T27 Operator:T28 Value:T13 Temporal-Unit:T8
T28	Eq-Operator 152 160	at least
A7	Eq-Operator-Value T28 GTEQ
T29	Drug 175 203	Anabolic androgenic steroids
E11	Drug:T29 Name:T30
T30	Drug-Name 175 203	Anabolic androgenic steroids
T31	Drug 239 267	anabolic androgenic steroids
E12	Drug:T31 Name:T32 Temporality:E7 Duration:E13 Temporality2:E8
T32	Drug-Name 239 267	anabolic androgenic steroids
T33	Eq-Comparison 318 334	at least 2 years
E13	Eq-Comparison:T33 Operator:T34 Value:T16 Temporal-Unit:T10
T34	Eq-Operator 318 326	at least
A8	Eq-Operator-Value T34 GTEQ
T35	Eq-Unit 344 350	cycles
T36	Eq-Temporal-Unit 355 359	year
A9	Eq-Temporal-Unit-Value T36 year
R1	If-Then Arg1:E11 Arg2:E12	
T37	Drug 370 398	anabolic androgenic steroids
E14	Drug:T37 Name:T38
T38	Drug-Name 370 398	anabolic androgenic steroids
T39	Study 444 449	study
E15	Study:T39 
T40	Temporal-Connection 421 436	over the course
E16	Temporal-Connection:T40 Arg:E14 Arg2:E15
A10	Temporal-Connection-Type-Value E16 during
T41	Condition 481 490	sedentary
E18	Condition:T41 Name:T5
T5	Condition-Name 481 490	sedentary
T42	Life-Stage-And-Gender 491 494	men
A11	Life-Stage-And-Gender-Type T42 male
T43	Negation 495 502	without
E17	Negation:T43 Negates:E1
T44	Condition 552 559	Smoking
E19	Condition:T44 Name:T45
T45	Condition-Name 552 559	Smoking
T46	Observation 566 585	Alcohol consumption
E20	Observation:T46 Name:T47
T47	Observation-Name 566 585	Alcohol consumption
A12	Observation-Type-Value T47 social-habit
T48	Drug 599 608	diuretics
E21	Drug:T48 Name:T49
T49	Drug-Name 599 608	diuretics
T50	Drug 616 644	antihypertensive medications
E22	Drug:T50 Name:T51
T51	Drug-Name 616 644	antihypertensive medications
T52	Or 609 615	and/or
E23	Or:T52 Arg:E21 Arg2:E22
T53	Modifier 661 667	kidney
E24	Modifier:T53 Modifies:T7
T54	Modifier 651 656	Liver
E25	Modifier:T54 Modifies:T7
T55	Or 657 660	and
E26	Or:T55 Arg:E25 Arg2:E24
